These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19580850)

  • 1. Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment.
    Tantucci M; Mariucci G; Taha E; Spaccatini C; Tozzi A; Luchetti E; Calabresi P; Ambrosini MV
    Neuroscience; 2009 Oct; 163(3):735-40. PubMed ID: 19580850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction.
    Costa C; Tozzi A; Luchetti E; Siliquini S; Belcastro V; Tantucci M; Picconi B; Ientile R; Calabresi P; Pisani F
    Exp Neurol; 2010 Jan; 221(1):217-24. PubMed ID: 19913015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
    Kumar P; Kumar A
    Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
    Colle D; Hartwig JM; Soares FA; Farina M
    Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole body hyperthermia reduces oxidative stress in the striatum of rats in an animal model of mitochondrial toxicity with 3-nitropropionic acid.
    Medina-Navarro R; Guerrero-Linares I
    Int J Hyperthermia; 2009 Jun; 25(4):280-8. PubMed ID: 19440936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
    Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
    Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
    Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
    Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
    Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
    Pandey M; Varghese M; Sindhu KM; Sreetama S; Navneet AK; Mohanakumar KP; Usha R
    J Neurochem; 2008 Jan; 104(2):420-34. PubMed ID: 17953654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.
    Sandhir R; Sood A; Mehrotra A; Kamboj SS
    Neurodegener Dis; 2012; 9(3):145-57. PubMed ID: 22327485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
    Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
    Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity.
    Belcastro V; Tozzi A; Tantucci M; Costa C; Di Filippo M; Autuori A; Picconi B; Siliquini S; Luchetti E; Borsini F; Calabresi P
    Exp Neurol; 2009 May; 217(1):231-4. PubMed ID: 19416678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
    Chang KL; New LS; Mal M; Goh CW; Aw CC; Browne ER; Chan EC
    J Proteome Res; 2011 Apr; 10(4):2079-87. PubMed ID: 21355552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
    Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
    Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease.
    Pérez-De La Cruz V; Elinos-Calderón D; Robledo-Arratia Y; Medina-Campos ON; Pedraza-Chaverrí J; Ali SF; Santamaría A
    Behav Brain Res; 2009 May; 199(2):210-7. PubMed ID: 19100293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
    Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
    Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease.
    Dalbem A; Silveira CV; Pedroso MF; Breda RV; Werne Baes CV; Bartmann AP; da Costa JC
    Brain Res; 2005 Jun; 1047(2):148-58. PubMed ID: 15901483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A; Akula KK; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Nitropropionic acid neurotoxicity in organotypic striatal and corticostriatal slice cultures is dependent on glucose and glutamate.
    Storgaard J; Kornblit BT; Zimmer J; Gramsbergen JB
    Exp Neurol; 2000 Jul; 164(1):227-35. PubMed ID: 10877933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.